Anticoagulation control in hospitalised patients on warfarin

DSpace/Manakin Repository

Search OPUS

Advanced Search


My Account

Show simple item record Su, EY Naganathan, V Fallah, H Bajorek, BV McLachlan, AJ 2012-02-10T06:09:41Z 2008-12
dc.identifier.citation Journal of Pharmacy Practice and Research, 2008, 38 (4), pp. 292 - 295
dc.identifier.issn 1445-937X
dc.identifier.other C1UNSUBMIT en_US
dc.description.abstract Background: Anticoagulation control is a strong predictor of Iclinical outcomes for patients on warfarin. Aim: To identify instances of excessive anticoagulation in hospitalised patients on warfarin and to determine the causes of international normalised ratios (INRs) of 5 and above and the management strategies used to correct it. Method: An observational descriptive study undertaken at a teaching hospital over a 3-month period. Data were reviewed prospectively and retrospectively to measure the percentage of time patients were maintained within their target INR range while in hospital and to identify cases of excessive anticoagulation. Patients were divided into a control group (INR < 5) and a high INR group (INR ≥ 5). Possible causes of INRs of 5 and above and its management strategies were recorded. Results: Out of a total of 208 patients on warfarin identified in the geriatric, orthopaedic and cardiology wards, 144 patients met the study criteria. The mean percentage of time spent within, above and below the target INR range by the control group was 60%, 0% and 15%, and by the high INR group was 41%, 33% and 16%, respectively. In the high INR group, 26 possible causes of INRs of 5 and above were identified and the co-administration of roxithromycin and warfarin were implicated in 7 cases. Management strategies for INRs of 5 and above were compared between two stratified groups (INR 5-9 and INR ≥ 9). The management strategies adopted included warfarin dose reduction (83%; 86%), temporary withholding of warfarin (100%; 100%), administration of vitamin K (58%; 100%), fresh frozen plasma (13%; 43%) and prothrombin complex concentrate (8%; 29%). The time to return to the upper limit of the target INR range was INR 5-9 (1.6 SD 1.5 days) and INR ≥ 9 (0.5 SD 0.4 days). Conclusion: Anticoagulation control is difficult for hospital patients and drug interactions are an important contributing factor. The management strategies adopted to correct excessive anticoagulation followed the relevant guidelines.
dc.language eng
dc.title Anticoagulation control in hospitalised patients on warfarin
dc.type Journal Article
dc.parent Journal of Pharmacy Practice and Research
dc.journal.volume 4
dc.journal.volume 38
dc.journal.number 4 en_US
dc.publocation Australia en_US
dc.identifier.startpage 292 en_US
dc.identifier.endpage 295 en_US GSH.Pharmacy en_US
dc.conference Verified OK en_US
dc.for 1115 Pharmacology and Pharmaceutical Sciences
dc.personcode 112624
dc.percentage 100 en_US Pharmacology and Pharmaceutical Sciences en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US en_US
dc.location.activity en_US
dc.description.keywords NA en_US
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Graduate School of Health
pubs.organisational-group /University of Technology Sydney/Strength - Health Services and Practice Research
utslib.copyright.status Closed Access 2015-04-15 12:17:09.805752+10
utslib.collection.history Uncategorised (ID: 363)
utslib.collection.history Closed (ID: 3)

Files in this item

This item appears in the following Collection(s)

Show simple item record